I copied this from — I think CNBC — but my brain is addled with allergies..
Today is arguably the biggest day of the earnings season, with reports due after the closing bell from Microsoft (MSFT), Meta Platforms (META), Alphabet (GOOGL) and Amazon (AMZN). The companies are largely expected to post solid results, with investors and analysts eager for updates on the companies’ AI spending plans, which have drawn scrutiny from market participants in recent quarters. Traders are pricing in the likelihood of big moves in the stock prices of the tech giants following the reports. Investors have set a high bar for the results, which could either propel the broader market to new highs or slow a recent rally that has been fueled by tech sector gains.
Personally I’m hugely positive.
In his 2025 letter to shareholders (Amazon’s latest annual letter), Andy Jassy makes three key points about AWS demand and capacity:
He says “we have never seen a technology more quickly adopted than AI” and that “Amazon is smack in the middle of this land rush, and companies are choosing AWS for AI,” highlighting a more than 15 billion dollar AI revenue run rate inside AWS as of Q1 2026.
He notes AWS could be growing even faster but that “we still have capacity constraints that yield unserved demand,” even after adding 3.9 GW of new power capacity in 2025 and running AWS at a 142 billion dollar revenue run rate with 24% year-over-year growth.
He gives a concrete example that “two large AWS customers have already asked if they could buy all of our Graviton instance capacity in 2026 … we can’t agree to these requests given other customers’ needs, but it gives you an idea of the demand.”
So in the official shareholder letter, the framing is: demand is exceptionally strong, AWS is adding power and capacity as fast as it can, and there is still unserved demand, particularly for its own chips and AI infrastructure.
I’ve got a huge backlog of stuff I want to talk about. But allergies got in the way.
A day or so ago, I started a blog:
We are at war. Our stocks go up.
Go figure.
Except for my “sure-fire” company — Israel’s biggest defense stock — goes down.
Go figure.
Some my loyal readers wondered if were alive. I am. And had anything to offer.
Not much.
My stock picks are working. It’s been pinching time. Pinch me. It’s been so good.
Working also are the trees in Columbia County, New York. They’re exploding with things (leaves and flowers) I’m allergic to.
Sneezing. coughing. Spluttering. Head aching. Everyone is complaining. Everyone has a pet remedy: Claritin, Flonase, Nyquil,
Benadryl, and Singulair (aka Montelukast) ….whose warning label reads like a one-way trip to the looney-bin or suicide chamber.
There’s nothing like hay fever’s varied symptoms to convince you that you’re dying. I spent an hour describing my symptoms to Perplexity and Gemini, seeking a magic cure, aka panacea.
No such luck.
My doctor, Jerry Clements knew best. He put me on azithromycin.
Singulair is the closest allergy cure-all. But the government rained on that parade: In 2020, the FDA added a
“boxed warning” (black box warning) for serious mental health side effects, including depression, agitation, sleep
issues, and suicidal thoughts.
All because our Columbia County trees are celebrating their new vibrant, verdant growths. (Nice adjectives?)
Sadly, Amazon doesn’t sell Agent Orange. Remember that earlier pointless war — Vietnam?
I’ll live in misery until Autumn when God kills all my irritants. and I have to spend a small fortune cleaning up his mess. There’s a song here about falling leaves… Don’t remind me.
See you later tonight when we’ve heard the earnings. They’ll be great.
Have you noticed that Nvidia is over $200? Thank you, Harry.
— Harry Newton
Big joy tonight in earnings.
